‘I Cannot Endorse Microdosing’: Local Doctor Warns on Ozempic Trend

Microdosing weight-loss drugs like Ozempic is trending on social media, but local medical experts warn against it. Dr. Dilendra Weerasinghe of Rochester Regional Health says there’s no FDA approval or clinical evidence supporting this use. Reasons for microdosing range from avoiding side effects to saving money, but he recommends exploring safer options, including bariatric surgery. The warning comes as obesity remains a major public health issue, requiring long-term lifestyle changes rather than shortcuts.

Advertisements

Source: Rochester First